SWOG clinical trial number
SWOG-8037

Combined Therapies for Squamous Cell Carcinoma of the Esophagus

Closed
Phase
II
Published
Abbreviated Title
Combined Therapies for Squamous Cell Carcinoma of the Esophagus
Activated
02/16/1981
Closed
01/19/1984

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1987

Combined therapies for squamous-cell carcinoma of the esophagus, Southwest Oncology Group study.

E Poplin;T Fleming;L Leichman;HG Seydel;Z Steiger;S Taylor;R Vance;WJ Stuckey;SE Rivkin JCO 5(4):622-628

1986

SWOG 8037: Combined therapy for squamous cell carcinoma of theesophagus (SCCE).

E Poplin;L Leichman;G Seydel;Z Steiger;T Fleming ASCO 5:80(#311)

1984

Pre-operative adjuvant therapy for squamous cell cancer (SCC) of the esophagus: SWOG & RTOG clinical trials.

L Leichman;HG Seydel;Z Steiger ASCO #C-575

Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: The Wayne State University, Southwest Oncology Group and Radiation Therapy Oncology Group experience.

L Leichman;Z Steiger;HG Seydel;VK Vaitkevicius Semin Oncol 11(2):178-185

Other Clinical Trials

SWOG Clinical Trial Number
SWOG-8037

Combined Therapies for Squamous Cell Carcinoma of the Esophagus

Research Committee(s)
Gastrointestinal Cancer
Activated
02/16/1981
Closed
01/19/1984
Closed
Phase
II
Published
SWOG Clinical Trial Number
SWOG-8591(NCI Intergroup #0035)

An Evaluation of Levamisole Alone or Levamisole plus 5-Fluorouracil as Surgical Adjuvant Treatment for Resectable Adenocarcinoma of the Colon

Research Committee(s)
Gastrointestinal Cancer
Activated
01/14/1985
Closed
10/01/1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8721

A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
09/01/1987
Closed
09/01/1991
Accrual
69%
Closed
Phase
II
Published